Last reviewed · How we verify
NCT04495218: DIA
NGS Panel of Incomplete Forms of Ocular Albinism
trial testing Blood samples in Albinism, Ocular in 53 participants. Completed in 28 February 2024.
28 February 2024
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 53 |
| Start date | 23 November 2020 |
| Primary completion | 28 February 2024 |
| Estimated completion | 28 February 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Blood samples — full drug profile →
Conditions studied
- Albinism, Ocular — all drugs for Albinism, Ocular →
Sponsor
University Hospital, Bordeaux
Who can join
0 and older, any sex, with Albinism, Ocular. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Implementation of a next-generation sequencing panel of genes to identify deleterious variants in patients with incomplete forms of albinism.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Crossed VEP asymmetry in a patient with AHR-linked infantile nystagmus and foveal hypoplasia.
Smirnov VM, Smirnov VM, Lasseaux E, Michaud V, et al · · 2024 · cited 2× · PMID 38922562 · DOI 10.1007/s10633-024-09979-6
Verify or expand the search:
- PubMed search for NCT04495218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood samples
Trials testing the same drug.
- NCT07460700 — Mesenteric Ischemia Markers Study · NA · recruiting
- NCT06996249 — Prospective Data Collection Initiative on Thoracic Malignancies · recruiting
- NCT06694363 — New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome · recruiting
- NCT06826066 — Involvement of the Immune System in Intrinsic Radiosensitivity · NA · recruiting
- NCT06864481 — Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis · recruiting
Other recruiting trials for Albinism, Ocular
Currently open trials in the same condition.
- NCT06345976 — Functional Impairment in Albinism · recruiting
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04495218 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04495218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing